This site is intended for healthcare professionals only
LoginRegister
Zydus Lifesciences subsidiary bags USFDA nod to market pulmonary arterial hypertension drug SelexipagZydus Lifesciences subsidiary bags USFDA nod to market pulmonary arterial hypertension drug...
Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to StelaraBiocon Biologics recognized as Company with Great Managers at Great Manager Awards 2022
Alembic Pharma gets four USFDA observations for Panelav facilityAlembic Pharma gets PAS approval from USFDA for Pregabalin Capsules
Merck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial CancerMerck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial Cancer
Shilpa Medicare unveils Capecitabine 1000 MG dispersible tablet for breast cancerShilpa Medicare unveils Capecitabine 1000 MG dispersible tablet for breast cancer
Boehringer Ingelheim appoints Shashank Deshpande, Paola Casarosa to Board of Managing DirectorsBoehringer Ingelheim appoints Shashank Deshpande, Paola Casarosa to Board of Managing Directors
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for EnhertuRoche Actemra gets USFDA okay to treat COVID in hospitalised adults
Lupin Diagnostics launches Regional Reference Laboratory in IndoreLupin Diagnostics launches Regional Reference Laboratory in Indore
Daiichi Sankyo unveils Blood cancer drug EZHARMIA in JapanDaiichi Sankyo unveils Blood cancer drug EZHARMIA in Japan
Adverse drug reactions from normal saline: Punjab imposes 3-year ban on Captab BiotechIPCA Labs, Cadila Healthcare among 16 Indian pharma firms blacklisted in Nepal
Indian pharma sector set for volume to value leadership journey in 2023Indian pharma sector set for volume to value leadership journey in 2023
Lupin, Natco Launch Bosentan Tablets in US With 180-Day ExclusivityLupin bags USFDA nod for generic equivalent of Briviact Tablets
X